UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041502
Receipt number R000047381
Scientific Title Combined effect of acupuncture and acupressure on lowering blood pressure: a pilot study
Date of disclosure of the study information 2020/09/01
Last modified on 2023/12/25 15:32:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Combined effect of acupuncture and acupressure on lowering blood pressure: a pilot study

Acronym

Acupuncture and acupressure for lowering blood pressure

Scientific Title

Combined effect of acupuncture and acupressure on lowering blood pressure: a pilot study

Scientific Title:Acronym

Acupuncture and acupressure for lowering blood pressure

Region

Japan


Condition

Condition

Hypertension/High-normal blood pressure

Classification by specialty

Cardiology Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effect of combined therapy of acupuncture and acupresseure

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Systolic and diastolic pressure
Home blood pressure (morning/evening, 3 days)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Acupuncture treatment (1 session/week, total 4 sessions)
Acupressure (everyday at participant's home, total 28 sessions)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

35 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1 Those who are able to join in the first and last examination.
2 Those with systolic blood pressure (SBP) 130 mmHg or diastolic blood pressure (DBP) 85 mmHg.
3 Those who joined in the explanation session and gave written informed consent.

Key exclusion criteria

1 Those who have hypertension (SBP 140/ DBP 90) and who does not have the permission of doctor.
2 Those with secondary hypertension (diabetes mellitus, chronic kidney disease, endocrine disease etc).
3 Those with stage 2 hypertension (SBP 180 mmHg/DBP 110 mmHg).
4 Those with history of stroke or Myocardial infarction.
5 Pregnant women during this study period.
6 Those with metal allergies.
7 Those who are judged by the principal investigator to be unsuitable as a research subject.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Kiyohide
Middle name
Last name Tomooka

Organization

Juntendo University

Division name

Department of Public Health, Faculty of Medicine

Zip code

113-8421

Address

2-1-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-5802-1049

Email

k-tomoka@juntendo.ac.jp


Public contact

Name of contact person

1st name Kiyohide
Middle name
Last name Tomooka

Organization

Juntendo University

Division name

Department of Public Health, Faculty of Medicine

Zip code

113-8421

Address

2-1-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-5802-1049

Homepage URL


Email

k-tomoka@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo Clinical Research and Trial Center

Address

3-1-3, Hongo, Bunkyo-ku, Tokyo

Tel

03-3814-5672

Email

kenkyu5858@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 07 Month 13 Day

Date of IRB

2020 Year 07 Month 17 Day

Anticipated trial start date

2020 Year 09 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 08 Month 21 Day

Last modified on

2023 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047381


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name